Sichuan Biokin Pharmaceutical Co (SHSE:688506) Long-Term Capital Lease Obligation : ¥14 Mil (As of Sep. 2024)

View and export this data going back to 2023. Start your Free Trial

What is Sichuan Biokin Pharmaceutical Co Long-Term Capital Lease Obligation?

Sichuan Biokin Pharmaceutical Co's Long-Term Capital Lease Obligation for the quarter that ended in Sep. 2024 was ¥14 Mil.

Sichuan Biokin Pharmaceutical Co's quarterly Long-Term Capital Lease Obligation increased from Mar. 2024 (¥3 Mil) to Jun. 2024 (¥16 Mil) but then declined from Jun. 2024 (¥16 Mil) to Sep. 2024 (¥14 Mil).

Sichuan Biokin Pharmaceutical Co's annual Long-Term Capital Lease Obligation declined from Dec. 2021 (¥9 Mil) to Dec. 2022 (¥6 Mil) and declined from Dec. 2022 (¥6 Mil) to Dec. 2023 (¥1 Mil).

Sichuan Biokin Pharmaceutical Co Long-Term Capital Lease Obligation Historical Data

The historical data trend for Sichuan Biokin Pharmaceutical Co's Long-Term Capital Lease Obligation can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Sichuan Biokin Pharmaceutical Co Long-Term Capital Lease Obligation Chart

Sichuan Biokin Pharmaceutical Co Annual Data

Trend

Dec11

Dec12

Dec13

Dec14

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Long-Term Capital Lease Obligation

Get a 7-Day Free Trial

5.22

8.97

5.72

1.02

Sichuan Biokin Pharmaceutical Co Quarterly Data
	Dec13	Dec14	Jun15	Dec18	Dec19	Dec20	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24
Long-Term Capital Lease Obligation	Get a 7-Day Free Trial															2.12	1.02	3.41	15.75	14.29

Sichuan Biokin Pharmaceutical Co (SHSE:688506) Long-Term Capital Lease Obligation Explanation

Long-Term Capital Lease Obligation are the amount due for long-term asset lease agreements that are nearly equivalent to asset purchases. Capital lease obligations are installment payments that constitute a payment of principal plus interest for the capital lease. The Short-Term Capital Lease Obligation is the portion of a Long-Term Capital Lease Obligation that is due over the next year.

Under US Generally Accepted Accounting Principles (GAAP), a capital lease is essentially equivalent to a purchase by the lessee if it meets the following criteria:

1. Ownership of the asset is transferred to the lessee at the end of the lease term;
2. The lease contains a bargain purchase option to buy the equipment at less than fair market value;
3. The lease term equals or exceeds 75% of the asset's estimated useful life;
4. The present value of the lease payments equals or exceeds 90% of the total original cost of the equipment.

Sichuan Biokin Pharmaceutical Co Long-Term Capital Lease Obligation Related Terms

Thank you for viewing the detailed overview of Sichuan Biokin Pharmaceutical Co's Long-Term Capital Lease Obligation provided by GuruFocus.com. Please click on the following links to see related term pages.

Sichuan Biokin Pharmaceutical Co Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Sichuan Biokin Pharmaceutical Co Ltd (SHSE:688506) » Definitions » Long-Term Capital Lease Obligation

Traded in Other Exchanges

N/A

Address

No. 161, Baili Road, No. 1, Building 1, Cross-strait Science and Technology Industrial Park, Wenjiang District, Sichuan Province, Chengdu, CHN, 611130

Website

http://en.baili-pharm.com

Sichuan Biokin Pharmaceutical Co Ltd is a chemical drug and biological drug-based company that integrates drug research and development, production and marketing.

Executives

Zhu Yi

Directors, senior managers

Sichuan Biokin Pharmaceutical Co Headlines

No Headlines